3D Printing

Dr. Michael A. Repka is Distinguished Professor of the Department of Pharmaceutics at The University of Mississippi. He is also Founder and Director of the Pii Center for Pharmaceutical Technology. His research interests include the solubilization and delivery of poorly soluble bioactives via Hot Melt Extrusion (HME) technology, while coupling HME techniques with 3D printing to produce patient centric delivery systems . Dr. Repka has established himself as an expert in this major pharmaceutical processing field through his numerous peer-reviewed publications, presentations and scientific talks.Dr. Nigel Langley is currently the Global Technical Director, Life Sciences at Gaylord Chemical LLC. He has a strong interest in excipient innovation, solubilization, hot melt extrusion and 3D printing.  Dr. Langley has also worked at BASF and Croda International PLC and is the current Chair of IPEC-Americas.

• Overview of Pharmaceutical 3D Printing Technologies.- Clinical Benefit of 3D Printed Products.- Characterization or Quality Control of 3D Printed Products.- Polymers for HME based 3D Printing.- Cellulosic Polymers.-  API and Polymer Selection Formulation and Process Variables.-  Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D.-  Future Trends Including Novel Polymeric Excipients  Designed for Purpose Bioprinting.